Phase2 Study of TS-141 in Child Patients With ADHD (Double-blind, Parallel Group Study)
Phase 2
Completed
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Registration Number
- JPRN-jRCT2080223189
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Child patients diagnosed with ADHD
- Outpatients
etc.
Exclusion Criteria
- Having other central nervous system disease
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>efficacy(frequency of ADHD)
- Secondary Outcome Measures
Name Time Method efficacy<br>efficacy(degree of ADHD,QOL etc)